UAE’s Mubadala acquires US-based Dental Care Alliance

Mubadala Investment Company (Mubadala) has acquired Dental Care Alliance (DCA), a leading US-based dental services organisation with approximately 390 allied practices, alongside funds managed by Harvest Partners, an established private equity firm focused on investing in middle-market companies.

Founded in 1991, DCA has approximately 5,400 employees, including over 885 dentists in 22 states, and welcomes over 3.5 million patient visits per year.

Funds managed by Harvest Partners acquired DCA in partnership with management in 2015.

Following the recapitalisation that closed in December 2022, Mubadala and funds managed by Harvest Partners jointly control DCA and will work closely with the management team.

Unlocking new opportunities for DCA

Alvin Teh, head of Consumer at Mubadala said, “Dental Care Alliance has a highly diversified range of services, a strong management team with a proven track record, and a scalable platform with a significant growth trajectory. We are delighted to be investing alongside Harvest Partners and, together, leveraging our combined resources and experience in the multi-site services sector to unlock new opportunities for DCA.

“The investment will allow DCA to further empower the exceptional dental professionals that we support as they deliver meaningful patient experiences and vital dental healthcare,” said Jerry Rhodes, Chief Executive Officer for Dental Care Alliance. “As we embark on the promising next chapter at DCA, we will accelerate and prioritise growth and innovation, individualized development for our team members, and transformational initiatives that put our allied practices first.”

In recent news, Mubadala and US-based National Resilience (Resilience), a technology-focused manufacturing company, signed a deal to further advance the UAE’s life sciences ecosystem through biopharma manufacturing. National Resilience is a biotechnology company headquartered in California in the US that is building a network of high-tech, end-to-end manufacturing solutions with the aim of ensuring that the existing and future needs for complex medicines are met quickly

Read: Mubadala, US-based Resilience to manufacture biopharma in UAE